Correlation Engine 2.0
Clear Search sequence regions

  • asthma (1)
  • bambuterol (15)
  • colitis (9)
  • colon (4)
  • cytokines (1)
  • dextran (3)
  • il 17 receptor (1)
  • IL 6 (2)
  • macrophages (1)
  • mice (5)
  • orphan (1)
  • RORγt (1)
  • signal (1)
  • sodium (1)
  • spleen (1)
  • STAT3 (1)
  • weight (1)
  • weight loss (2)
  • β2AR (2)
  • Sizes of these terms reflect their relevance to your search.

    Bambuterol (BMB) has been used clinically to treat asthma due to its bronchodilation activity. However, the effect of BMB on ulcerative colitis (UC) has not been examined. The present work focused on the effects of enantiomeric BMB on UC. Acute UC was induced in mice by 3% dextran sulfate sodium (DSS), and (R)-, (S) and (RS)-BMB were orally administered. Body weight loss and the disease activity index (DAI) were measured once a day. Inflammatory factors were detected by ELISA and qRT-PCR. Histological evaluations of colon samples were performed. IL-6, STAT3, and RORγt pathway-related proteins were analyzed by western blotting. The results verified that colitis severity was dramatically ameliorated by (R)-BMB, which was significantlybetter than the effect of (RS)-BMB or (S)-BMB, as evidenced by body weight loss, DAI, colon length, spleen/body weight ratio and histopathological manifestations. Furthermore, (R)-BMB treatment significantly diminished the levels of inflammatory cytokines and macrophages infiltration in mice with colitis. Besides, treated with (R)-BMB obviously elevated the level of β2AR. In addition, (R)-BMB decreased the expression of IL-6, IL-17, retinoic acid receptor-related orphan receptor-gamma t (RORt), and phosphorylated STAT3 (p-STAT3) in a dose-dependent manner in the colon tissues. The efficacy of (R)-BMB was more notable than aminosalicylic acid (5-ASA). (R)-BMB is either butyrilcholinesterase inhibitor or β2AR agonist which offers new treatment of colitis. Copyright © 2021 Elsevier B.V. All rights reserved.


    Liangjun Deng, Shanping Wang, Haihua Guo, Xiaoming Liu, Xinfeng Zou, Rui Zhang, Yue Lin, Wen Tan. RS)-bambuterol and its enantiomers: Potential improvement of (R)-bambuterol in mice with colitis. International immunopharmacology. 2022 Feb;103:108501

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 34974400

    View Full Text